DEF 14AThe Ballot
Damora Therapeutics, Inc. files DEF 14A
Filed Apr 14, 2021 · 5y ago · Accession 0001564590-21-018763
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Damora Therapeutics, Inc.
- Ticker
- DMRA
- CIK
- 1800315
- Form type
- DEF 14A
- Filing date
- Apr 14, 2021
- Report date
- May 26, 2021
- Document
- glto-def14a_20210526.htm
- Size
- 1.1 MB